Drugs & Targets Tecentriq receives priority review for treatment of urothelial carcinoma January 25, 2017Vol.40 No.01
NewVac Meets Primary Endpoints in Phase II Trial of Quisinostat Combination in Platinum-Resistant Disease January 25, 2017Vol.40 No.01
MammaPrint Substantially Impacts How Breast Cancer in Germany is Treated January 25, 2017Vol.40 No.01
